Adding Apalutamide to Perioperative ADT Associated with Better Outcomes of Radical Prostatectomy for High-Risk Localised or Locally Advanced Prostate Cancer By Ogkologos - June 3, 2026 222 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PROTEUS study Source RELATED ARTICLESMORE FROM AUTHOR Giredestrant plus everolimus prolongs PFS among patients with ER-positive, HER2-negative, ESR1-mutated advanced breast cancer after the receipt of a CDK4/6 inhibitor EMA Recommends Granting a Marketing Authorisation for Ensartinib Taking on the RAS Challenge MOST POPULAR FDA Approves Polatuzumab Vedotin-piiq for Previously Untreated Diffuse Large B-Cell Lymphoma,... April 27, 2023 Coronavirus Vaccines and People with Cancer: A Q&A with Dr. Steven... February 10, 2021 ΚΑΡΚΙΝΟΣ ΘΥΡΕΟΕΙΔΟΥΣ ΑΔΕΝΑ July 22, 2019 FDA Grants Accelerated Approval to Sunvozertinib for Metastatic Non-Small Cell Lung... July 25, 2025 Load more HOT NEWS Woman, 88, Had Been Waving from Her Window for Over a... Study Finds the Cost of Treating Metastatic Breast Cancer Could More... Grieving for Your Old Life After Cancer The 10-year cancer plan: is improving cancer survival still a priority...
